Literature DB >> 11864891

Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.

B Sander1, M Larsen, C Engler, C Strøm, B Moldow, N Larsen, H Lund-Andersen.   

Abstract

AIM: To evaluate the relation between the quantitative measurement of vitreous fluorescein with fluorescein angiography and retinopathy in diabetic patients with and without clinically significant macular oedema (CSMO).
METHODS: In a prospective cross sectional study, passive permeability and active, outward transport of fluorescein across the blood-retinal barrier were quantitated with vitreous fluorometry in 61 eyes from 48 patients with CSMO and 22 fellow eyes without CSMO, after exclusion of eyes with previous macular laser treatment and vitreous liquification. All patients were recruited from the university hospital's outpatient clinic. Retinopathy and fluorescein angiograms were evaluated on 60 degree photographs.
RESULTS: The passive permeability in CSMO was significantly correlated with the severity of leakage on fluorescein angiograms (r=0.73), the level of retinopathy (r=0.61), and visual acuity (r=0.45). Significant differences between eyes with CSMO and eyes without CSMO were found for passive permeability (p<0.001), fluorescein leakage (p<0.001), visual acuity (p=0.02), and retinopathy (p=0.002).
CONCLUSION: Passive permeability of fluorescein quantitated with vitreous fluorometry was correlated both with semiquantitative fluorescein angiography and retinopathy, and a significant increase in passive permeability was found when comparing eyes with CSMO to eyes without CSMO. No such pattern was found for the active transport indicating that passive and not the outward, active transport is the factor of most importance in the development of CSMO.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864891      PMCID: PMC1771034          DOI: 10.1136/bjo.86.3.316

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  30 in total

1.  Fitting numerical solutions of differential equations to experimental data: a case study and some general remarks.

Authors:  P Dalgaard; M Larsen
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

2.  Lens fluorometry: light-attenuation effects and estimation of total lens transmittance.

Authors:  M Larsen; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.

Authors:  C Engler; B Krogsaa; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Retinal thickness analysis for quantitative assessment of diabetic macular edema.

Authors:  M Shahidi; Y Ogura; N P Blair; M M Rusin; R Zeimer
Journal:  Arch Ophthalmol       Date:  1991-08

7.  Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide.

Authors:  M Larsen; P Dalgaard; H Lund-Andersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  Quantitative vitreous fluorophotometry applying a mathematical model of the eye.

Authors:  H Lund-Andersen; B Krogsaa; M la Cour; J Larsen
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

9.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

10.  Blood-retinal barrier permeability versus diabetes duration and retinal morphology in insulin dependent diabetic patients.

Authors:  B Krogsaa; H Lund-Andersen; J Mehlsen; L Sestoft
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-12
View more
  8 in total

1.  Agreement between clinical estimation and a new quantitative analysis by Photoshop software in fundus and angiographic image variables.

Authors:  Alireza Ramezani; Hamid Ahmadieh; Mohsen Azarmina; Masoud Soheilian; Mohammad H Dehghan; Mohammad R Mohebbi
Journal:  Int Ophthalmol       Date:  2008-09-19       Impact factor: 2.031

2.  Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier.

Authors:  B Sander; M Larsen; C Engler; B Moldow; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

3.  A 5-year follow-up of photocoagulation in diabetic macular edema: the prognostic value of vascular leakage for visual loss.

Authors:  Birgit Sander; Per Hamann; Michael Larsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-26       Impact factor: 3.117

Review 4.  Diabetic macular edema: what is focal and what is diffuse?

Authors:  David J Browning; Michael M Altaweel; Neil M Bressler; Susan B Bressler; Ingrid U Scott
Journal:  Am J Ophthalmol       Date:  2008-09-05       Impact factor: 5.258

5.  Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.

Authors:  Sven Radetzky; Peter Walter; Sascha Fauser; Kan Koizumi; Bernd Kirchhof; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-03-23       Impact factor: 3.117

6.  Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.

Authors:  Paul Canning; Josephine V Glenn; Daniel K Hsu; Fu-Tong Liu; Tom A Gardiner; Alan W Stitt
Journal:  Exp Diabetes Res       Date:  2007

7.  A Quantitative Approach to Predict Differential Effects of Anti-VEGF Treatment on Diffuse and Focal Leakage in Patients with Diabetic Macular Edema: A Pilot Study.

Authors:  Michael J Allingham; Dibyendu Mukherjee; Erin B Lally; Hossein Rabbani; Priyatham S Mettu; Scott W Cousins; Sina Farsiu
Journal:  Transl Vis Sci Technol       Date:  2017-03-21       Impact factor: 3.283

8.  ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data.

Authors:  Pravin U Dugel; Joanna H Campbell; Szilárd Kiss; Anat Loewenstein; Vanessa Shih; Xiaoshu Xu; Nancy M Holekamp; Albert J Augustin; Allen C Ho; Victor H Gonzalez; Scott M Whitcup
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.